Seeing Is Believing
CINC is currently covered by 4 analysts with an average price target of $25.82. This is a potential upside of $25.82 (0%) from yesterday's end of day stock price of $0.
CinCor Pharma's activity chart (see below) currently has 3 price targets and 14 ratings on display. The stock rating distribution of CINC is 90.91% BUY and 9.09% HOLD.
Analysts average stock forecasts to be materialized ratio is 41.67% with an average time for these price targets to be met of 80.25 days.
Highest price target for CINC is $35, Lowest price target is $12, average price target is $25.82.
Most recent stock forecast was given by JEFFREY HUNG from MORGAN STANLEY on 10-Jan-2023. First documented stock forecast 01-Feb-2022.
Currently out of the existing stock ratings of CINC, 10 are a BUY (90.91%), 1 are a HOLD (9.09%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
30
$0.94 (3.23%)
22
1 years 3 months 28 days ago
3/6 (50%)
$1.2 (4.17%)
30
Buy
50
$20.94 (72.06%)
30
1 years 5 months 8 days ago
1/2 (50%)
$38.2 (323.73%)
188
Buy
60
1 years 5 months 9 days ago
2/3 (66.67%)
$25 (71.43%)
103
Buy
53
$23.94 (82.38%)
73
1 years 5 months 10 days ago
0/2 (0%)
$38.89 (275.62%)
What is CINC (CinCor Pharma) average time for price targets to be met?
Which analyst has the current highest performing score on CINC (CinCor Pharma) with a proven track record?
Which analyst has the current lower performing score on CINC (CinCor Pharma) with a proven track record?
Which analyst has the most public recommendations on CINC (CinCor Pharma)?
Which analyst is the currently most bullish on CINC (CinCor Pharma)?
Which analyst is the currently most reserved on CINC (CinCor Pharma)?